Fundacion SEIMC-GESIDA   Report issue

Foundation Phase 2 Phase 4
Founded: Madrid Spain (2008)

Organization Overview

First Clinical Trial
2008
NCT00866021
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fundacion SEIMC-GESIDA